Cargando…

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk

Detalles Bibliográficos
Autores principales:	Zheutlin, Alexander R., Zhang, Mingyuan, Conroy, Molly B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804006/ https://www.ncbi.nlm.nih.gov/pubmed/36593972 http://dx.doi.org/10.1016/j.ajpc.2022.100450

Ejemplares similares

Age-Based Disparities in Guideline-Recommended Statin Initiation for Primary Prevention Among Statin-Naive Adults
por: Zheutlin, Alexander R., et al.
Publicado: (2023)

Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment
por: Xu, Zhe, et al.
Publicado: (2021)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
por: Gobbel, Glenn T., et al.
Publicado: (2021)

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
por: Guo, Yi, et al.
Publicado: (2020)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
por: Hammond, Michael M., et al.
Publicado: (2023)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Race/Ethnic Differences in Atherosclerotic Cardiovascular Disease Risk Factors Among Patients With Hypertension: Analysis From 143 Primary Care Clinics
por: Khatib, Rasha, et al.
Publicado: (2021)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
por: Wang, Miao, et al.
Publicado: (2020)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
por: Ryou, In Sun, et al.
Publicado: (2022)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2022)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Estimated versus observed 10-year atherosclerotic cardiovascular event rates in a rural population-based health initiative: The Heart of New Ulm Project
por: Van Hove, Christopher, et al.
Publicado: (2022)

Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement
por: Belardo, Danielle, et al.
Publicado: (2022)

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease
por: Sajja, Aparna, et al.
Publicado: (2021)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Does Losing 5-7% of Prediabetic Body Weight from a Diabetes Prevention Program decrease Cardiovascular Risks?
por: Kucera, Molly, et al.
Publicado: (2021)

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis
por: Boettiger, David C., et al.
Publicado: (2021)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Chidambaram, Vignesh, et al.
Publicado: (2021)

Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis
por: Desai, Nihar R., et al.
Publicado: (2022)

Moral Dilemmas and Existential Issues Encountered Both in Psychotherapy and Philosophical Counseling Practices
por: Popescu, Beatrice A.
Publicado: (2015)

Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey
por: Nasir, Khurram, et al.
Publicado: (2022)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study
por: Ambrosy, Andrew P., et al.
Publicado: (2021)

Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
por: Satish, Priyanka, et al.
Publicado: (2021)

Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
por: West, Amy M, et al.
Publicado: (2009)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
por: Lee, Myunhee, et al.
Publicado: (2023)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bt3vrodoa2kgqap563276n7fti